> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears BD ‘Novel’ Blood Sampler
- URL: https://www.fdaweb.com/fda-clears-bd-novel-blood-sampler/
- Published: 2023-12-07T12:00:00.000Z
- Updated: 2026-09-14T14:18:06.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5155943

FDA has cleared a Becton Dickinson 510(k) for what it describes as a “novel blood collection device” that gathers blood samples from a fingerstick that produces lab-quality results for some of the most commonly ordered blood tests.

“The BD MiniDraw Capillary Blood Collection System is less invasive than a traditional venous blood draw by using capillary blood collected from a patient’s finger by a trained healthcare worker, without the need for a phlebotomist to collect blood from a vein,” the company says, adding that this makes it more convenient for patients because it expands access to blood collection to new locations, including retail pharmacies. “The device may provide a better patient experience and has the potential to transform diagnostic testing,” it says.

The agency clearance covers low-volume blood collection for a lipid panel, selected chemistry tests, and hemoglobin and hematocrit testing, which are some of the most common tests ordered for monitoring hypertension to high cholesterol, BD says.